3
Hohmann, N; Mikus, G; Czock, D Effects and Risks Associated with Novel Psychoactive Substances: Mislabeling and Sale as Bath Salts, Spice, and Research Chemicals Dtsch Arztebl Int 2014; 111(9): 139-47; DOI: 10.3238/arztebl.2014.0139

Hohmann, N; Mikus, G; Czock, D Effects and Risks Associated with Novel Psychoactive Substances: Mislabeling and Sale as Bath Salts, Spice, and Research

Embed Size (px)

Citation preview

Page 1: Hohmann, N; Mikus, G; Czock, D Effects and Risks Associated with Novel Psychoactive Substances: Mislabeling and Sale as Bath Salts, Spice, and Research

Hohmann, N; Mikus, G; Czock, DEffects and Risks Associated with Novel Psychoactive Substances: Mislabeling and Sale as Bath Salts, Spice, and Research ChemicalsDtsch Arztebl Int 2014; 111(9): 139-47; DOI: 10.3238/arztebl.2014.0139

Page 2: Hohmann, N; Mikus, G; Czock, D Effects and Risks Associated with Novel Psychoactive Substances: Mislabeling and Sale as Bath Salts, Spice, and Research

Hohmann, N; Mikus, G; Czock, DEffects and Risks Associated with Novel Psychoactive Substances: Mislabeling and Sale as Bath Salts, Spice, and Research ChemicalsDtsch Arztebl Int 2014; 111(9): 139-47; DOI: 10.3238/arztebl.2014.0139

Page 3: Hohmann, N; Mikus, G; Czock, D Effects and Risks Associated with Novel Psychoactive Substances: Mislabeling and Sale as Bath Salts, Spice, and Research

Hohmann, N; Mikus, G; Czock, DEffects and Risks Associated with Novel Psychoactive Substances: Mislabeling and Sale as Bath Salts, Spice, and Research ChemicalsDtsch Arztebl Int 2014; 111(9): 139-47; DOI: 10.3238/arztebl.2014.0139